A Multicentre Study of Thromboprophylaxis in Pregnancy

Hdl Handle:
http://hdl.handle.net/10147/621373
Title:
A Multicentre Study of Thromboprophylaxis in Pregnancy
Authors:
Crowley, MP; Noone, C; Higgins, JR; O Shea, S
Publisher:
Irish Medical Journal
Journal:
Irish Medical Journal
Issue Date:
May-2017
URI:
http://hdl.handle.net/10147/621373
Abstract:
Venous thromboembolism (VTE) is a leading cause of maternal mortality. The risk increases with increasing maternal age, mode of delivery and medical co-morbidities. Thromboprophylaxis with low molecular weight heparin (LMWH) has been shown to be both safe and efficacious. The aim of this study was to prospectively investigate the incidence of maternal risk factors in pregnant women admitted to hospital, to calculate their VTE risk status and to investigate if they were receiving appropriate thromboprophylaxis. All patients admitted to the participating hospitals on the day of investigation were assessed for risk of VTE on the basis of hospital chart review. Five Hundred and forty women were recruited from 16 hospitals. Almost 32% (31.7%) were receiving thromboprophylaxis with LMWH. Just under 80% of patients were on the correct thromboprophylaxis strategy as defined by the RCOG guideline but 49% were under-dosed. The odds of receiving appropriate thromboprophylaxis were significantly increased if the woman was >35 years 0or with parity>3.
Item Type:
Article
Language:
en
Keywords:
PREGNANCY; THROMBOEMBOLISM

Full metadata record

DC FieldValue Language
dc.contributor.authorCrowley, MPen
dc.contributor.authorNoone, Cen
dc.contributor.authorHiggins, JRen
dc.contributor.authorO Shea, Sen
dc.date.accessioned2017-05-17T11:11:22Z-
dc.date.available2017-05-17T11:11:22Z-
dc.date.issued2017-05-
dc.identifier.urihttp://hdl.handle.net/10147/621373-
dc.description.abstractVenous thromboembolism (VTE) is a leading cause of maternal mortality. The risk increases with increasing maternal age, mode of delivery and medical co-morbidities. Thromboprophylaxis with low molecular weight heparin (LMWH) has been shown to be both safe and efficacious. The aim of this study was to prospectively investigate the incidence of maternal risk factors in pregnant women admitted to hospital, to calculate their VTE risk status and to investigate if they were receiving appropriate thromboprophylaxis. All patients admitted to the participating hospitals on the day of investigation were assessed for risk of VTE on the basis of hospital chart review. Five Hundred and forty women were recruited from 16 hospitals. Almost 32% (31.7%) were receiving thromboprophylaxis with LMWH. Just under 80% of patients were on the correct thromboprophylaxis strategy as defined by the RCOG guideline but 49% were under-dosed. The odds of receiving appropriate thromboprophylaxis were significantly increased if the woman was >35 years 0or with parity>3.en
dc.language.isoenen
dc.publisherIrish Medical Journalen
dc.subjectPREGNANCYen
dc.subjectTHROMBOEMBOLISMen
dc.titleA Multicentre Study of Thromboprophylaxis in Pregnancyen
dc.typeArticleen
dc.identifier.journalIrish Medical Journalen
dc.description.fundingNo fundingen
dc.description.provinceMunsteren
dc.description.peer-reviewpeer-reviewen
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.